Jci_page_head_homepage_01 Jci_page_head_homepage_02
Bin Ren, Yong Deng, Arpita Mukhopadhyay, Anthony A. Lanahan, Zhen W. Zhuang, Karen L. Moodie, Mary Jo Mulligan-Kehoe, Tatiana V. Byzova, Randall T. Peterson, Michael Simons
Published in Volume 120, Issue 4
J Clin Invest. 2010; 120(4):1217–1228 doi:10.1172/JCI39837
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 7
Restoration of ERK1/2 activation in vivo restores arteriogenesis in zebrafish.

(AE) Low- and high-power images of developing arterial vasculature in zebrafish embryos treated with vehicle (WT; A), synectin MO (B), or synectin MO plus GS4898 (C) or LY294002 (D), as described in Methods. Scale bars: 300 μm. (E) Quantitative analysis of ISV formation. P values vs. untreated control synectin knockdown are shown. (F) Effect of MEK inhibition on PI3K downregulation–induced ISV formation. Zebrafish embryos treated with vehicle or synectin MO were exposed to GS4898, LY294002, or 2 concentrations of U0126 as indicated. No effect on the extent of ISV formation was observed in WT embryos, whereas synectin MO–treated embryos exhibited complete inhibition of ISV formation. *P < 0.0001; **P = 0.0005. (G) Schema of PI3K/Akty1- Raf1/ER1/2 crosstalk. See text for details.